Roche says deal is a part of its personalized-medicine strategy, and is intended to speed up development of new cancer treatments.
The grant will help MeMed develop ImmunoPoC, a point-of-care test designed to detect whether a patient has a bacterial or viral infection.
Eurofins plans to immediately include GARDskin and the add-on test GARDpotency to cosmetic, chemical, and pharmaceutical clients worldwide.
ISB founder and pioneer of "P4 Medicine" details how systems biology approaches are being integrated with modern-day healthcare practices
In this webinar, multiplexing quantitative proteomics for profiling breast cancer patient-derived xenografts will be discussed.